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Abstract
The health impacts of airborne particulate matter (PM) are of global concern, and the direct
implications to the development/exacerbation of lung disease are immediately obvious. Most
studies to date have sought to understand mechanisms associated with PM exposure in adults/adult
animal models; however, infants are also at significant risk for exposure. Infants are affected
differently than adults due to drastic immaturities, both physiologically and immunologically, and
it is becoming apparent that they represent a critically understudied population. Highlighting our
work funded by the ONES award, in this review we argue the understated importance of utilizing
infant models to truly understand the etiology of PM-induced predisposition to severe, persistent
lung disease. We also touch upon various mechanisms of PM-mediated respiratory damage, with a
focus on the emerging importance of environmentally persistent free radicals (EPFRs)
ubiquitously present in combustion-derived PM. In conclusion, we briefly comment on strengths/
challenges facing current PM research, while giving perspective on how we may address these
challenges in the future.
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PARTICULATE POLLUTION
Airborne particulate matter (PM) is generated by a variety of sources including vehicular
exhaust, flaring of hydrocarbons at refineries, coal burning at power plants, and thermal
treatments of hazardous wastes. PM is often categorized according to mean aerodynamic
diameter with sizes ranging from coarse particles (2.5–10 μm in diameter) to the smaller
fine (<2.5 μm) and ultrafine (<0.1 μm) particles. The smaller classes of PM are more apt to
cause respiratory toxicity and dysfunction due to their propensity to deposit deep in the
lower airways and alveoli [1]. Owing to the increasing knowledge of the detrimental health
consequences of exposure to PM, the United States Environmental Protection Agency (US
EPA) through the Clean Air Act has set National Ambient Air Quality Standards (NAAQS).
The current recommendations for PM2.5 and PM10 are 35 and 150 μg/m3 within a 24-h
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period, respectively, whereas the annual limit of exposure for PM2.5 is 15 μg/m3 [2]. The
World Health Organization (WHO) is more stringent with daily exposure limits for PM2.5
and PM10 with concentrations set at less than 25 and 50 μg/m3, respectively; and an annual
PM2.5 limit at less than 10 μg/m3 [3, 4]. There are no current recommendations for daily or
annual exposure limits for ultrafine particles either nationally or globally. Astoundingly, the
WHO estimates that if air quality guidelines were met, an estimated 1.09 million premature
deaths would have been prevented in 2008 [5,6].
Although extensive research has focused on outdoor air pollution, indoor air pollution (IAP)
also poses a significant health risk. Most IAP is a mixture of cigarette smoke and/or biomass
combustion from cooking stoves—the products of which contain similar organic species as
found in outdoor air pollution. Those with the greatest risk from exposure to IAP are, as
expected, those who are exposed for the longest period of time (i.e., women, infants, young
children, and the elderly) and/or those with underlying immune/pulmonary/cardiovascular
disorders. Worldwide, exposure to IAP contributes to nearly two million premature deaths
annually due to acute lower respiratory tract infections in children under five, chronic
obstructive pulmonary disease in adults (equivalent to a lifetime of cigarette smoking), and
respiratory tract cancers in adults [7, 8]. There are additional known and suspected health
risks associated with exposure to IAP such as low birth weight, anemia, stunted growth in
infants and children [9, 10], interstitial lung disease, increased incidence of tuberculosis
[11], cardiovascular disease [12, 13], and cataracts [14,15]. IAP is thought to have such an
impact on public health that the U.S. government has committed more than $50 million to
alleviate its negative consequences through the Global Partnerships Initiative and
contributions to NIH's ongoing research funds [7]. This article briefly reviews the health
effects associated with combustion generated PM in infants focusing on the respiratory
effects and proposes a new mechanism for their role in respiratory disease.
ENVIRONMENTALLY PERSISTENT FREE RADICALS: RESPONSIBLE FOR
THE HEALTH IMPACTS OF PM?
It has been demonstrated that size, shape, and composition of PM are important factors in
determining toxicity [16, 17]. In addition, organic pollutants are often associated with PM
[18]. It was originally presumed that organic pollutants must be weakly associated (i.e., Van
der Waals, hydrogen bonds) with PM; however, studies have demonstrated that organic
pollutants can be surface-bound to PM and stubbornly resistant to removal, implying a much
stronger chemical bond [19]. Indeed, several pioneering studies by our colleagues
demonstrated that particular aromatic hydrocarbons chemisorb to the surface of PM through
transition metal oxides [20–23]. This environmental phenomenon results in the production
of a surface-stabilized free radical species. These radical species are very weakly reactive
with O2 giving the ability to persist in ambient air for extended periods of time (hours-
months) and at least 12 h in biological fluids (Figure 1). The stability of the radical is partly
due to stabilization on the surface of the particle, whereas the persistency in biological
systems is at least partially a result of a cyclic mechanism involving the biological
regeneration of reactive oxygen species (ROS) [24]. These environmentally persistent free
radicals (EPFRs) chemisorbed to PM are mostly semiquinone-type radicals similar to those
found in cigarette smoke [25], but we have also identified them associated with PM from
almost all combustion sources. Furthermore, there have been a number of studies concerning
radicals associated with environmental PM [26–29]. Large quantities of similar semiquinone
radicals have been found in PM collected from cities [22], with average radical
concentrations being ~10× higher for industrialized, highly populated locations than less
densely populated areas (unpublished observations). Radical concentrations in these
environmental samples, measured in spins/gram, were typically 2–10× higher than in
cigarette tar [30, 31], and each sample exhibited an electron paramagnetic resonance (EPR)
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spectrum with a g value of ~2.0033–2.004, which is typical of oxygen-centered or oxygen-
containing EPFRs. Owing to the recent discoveries of EPFRs, understanding of their impact
on health is in its infancy. Their radical and regenerative nature, however, suggests the
potential for causing dire health consequences, highlighting why further investigation is of
grave importance. We have been working to understand the mechanism of toxicity and
biological activity of EPFR-containing particles using in vitro and in vivo approaches; and
thus, it is the focus of this review even though we appreciate the chemical complexity of PM
and its many components (e.g., organics, particulates) that have also been shown to
contribute to damaging health effects.
INFANTS: A SPECIAL POPULATION AT RISK
PM and Feto-Infant Growth and Morbidity
Epidemiological data support a link between elevations in PM and exacerbation of
respiratory disease in adults [32, 33], and it is now widely accepted that exposure to PM
contributes to inflammatory airways diseases, such as asthma [34]. More recently,
investigators have begun to examine the effects of air pollution on infant/child health.
Although the majority of these studies are epidemiological and typically related to tobacco
smoke, they demonstrate a significant association between exposure to PM and feto-infant
morbidity outcomes such as low birth weight and preterm birth [35, 36]. One inhalation
study done in healthy humans concluded that particle deposition rate, when normalized to
surface area of the lung, was 35% higher in children compared to both adolescents and
adults [37]. Additional concerns, however, include increased incidence of placental
abruption in women exposed to PM levels that were well below EPA limits (PM2.5 > 10.97
μg/m3 and PM10 > 25.04 μg/m3) compared to those not exposed to those levels of PM [35].
Racial/ethnic disparities in the effects of PM on feto-infant morbidity outcomes were also
observed with African American infants being most at risk, suggesting that other factors
such as social economic status, education, or even surrounding environment may also be an
important confounding factor. A study in Korea suggested that area level social economic
status modified the effects of PM on preterm births [38], where those who resided in low
income areas had a higher probability of having a preterm birth when PM levels increased
by 10 μg/m3, specifically if these elevated exposures occurred in the second trimester. More
alarmingly, risk of respiratory death more than doubles for infants between the age of 7–12
months if exposure to elevated levels of PM occurred during the previous 6 months prior to
death [39].
PM and Asthma
Since PM affects the growth and development of the embryo/fetus, it is not surprising that
infants represent a particularly susceptible population to the effects of PM as they take in
more air per body weight, their lungs are still developing (i.e., at birth only 6.7–17.5% of the
alveoli are formed [40]), and they have immature immune systems. One of the main risk
factors for adult asthma is early life insults to the lung (both structurally and
immunologically) brought upon by environmental exposures [41]. Because of this, there has
been a surge in the number of studies attempting to understand the role of environmental
factors (i.e., particulate pollution or respiratory tract viral infections) in determining risk to
develop asthma/wheeze and other child respiratory health concerns (Figure 2A).
Unfortunately, still very few studies explore the interplay between all three factors (Figure
2B).
A large amount of epidemiological data exist linking elevated levels of PM and rate of
hospitalization for children with adverse pulmonary events such as asthma exacerbations
[42–46]. Indeed, several studies have demonstrated a positive correlation between PM
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exposure and lung function changes in children including decreases in forced vital capacity
(FVC), forced expiratory flow (FEF), and forced expiratory volume (FEV1) [47–50].
Furthermore, it has been shown that exposure to fine and ultrafine PM affects lung
development, resulting in functional deficits in the adult [51,52]. To further support the link
between early life exposure to PM and its effect on subsequent adult respiratory health,
histopathological lung changes such as septal enlargement, fibrosis, glandular hyperplasia,
and goblet cell metaplasia have been observed in autopsies of children less than 5 years of
age that had been exposed to biomass fuel [53]. In the majority of these children, these data
were consistent with pulmonary changes reminiscent of bronchitis.
PM and Viral Infection
A few epidemiological studies have associated risk for and severity of respiratory tract viral
infection with living near a source of traffic pollution, observing that infants who lived
closer to highways had an elevated risk of being hospitalized for severe influenza or
respiratory syncytial virus (RSV)-induced bronchiolitis [54, 55]. Moreover, elevated levels
of PM have been attributed to increased risk of postnatal mortality from respiratory tract
viral infections [56, 57]. Currently, the RESPIRE study is the only randomized, controlled
trial that has documented the benefits of reducing IAP on child pneumonia [58]. Data from
this study suggest that up to 90% of exposure reductions are required to attain significant
decreases in pneumonia risk and even a 22% risk reduction requires a 50% decrease in
exposure [59], highlighting the dramatic impact of PM on child health. Similar data are
obtained when looking specifically at exposure to diesel exhaust particles (i.e., increased
susceptibility, viral burden, and disease severity to respiratory viral infections including
influenza and RSV) [60–63].
Not only is there a clear association between increased ambient PM and hospitalization of
childhood bronchiolitis and respiratory disease, but it has also been demonstrated that there
is a corresponding increase in the amount of healthcare dollars spent annually [64].
Increases in healthcare cost are attributable to the increase in the amount of cases and the
enhanced severity of bronchiolitis due to increased PM exposure. In fact, it is estimated that
reducing levels of PM to just 7% below the current annual standard would save the U.S.
approximately $15 million annually in healthcare costs [64], giving us not only a medical
but an economic impetus to reduce combustion-derived PM emissions while also
encouraging further investigations on how PM enhances infectious disease severity.
Limited mechanistic research that does exist for infants/children demonstrate that exposure
to combustion-derived PM increases susceptibility to respiratory tract viral infections by
dampening the initial immunological response while skewing the pulmonary immune
response toward a T helper type 2 cell (Th2) response [65]—a response often seen in allergy
with corresponding antibody production that is predominantly immunoglobulin type E (IgE),
followed by an augmentation of downstream morbidities [66–69]. Altogether, these data
suggest that EPFR-containing PM (i.e., roadway PM and diesel exhaust particles) (1) may
be responsible for the increased risk for respiratory viral susceptibility and enhanced disease
and (2) has a significant impact on the developing respiratory tract. Hence, the role of
exposure to this class of PM on infantile susceptibility to viral infection is an area that
requires much more attention. Much of the current data are derived primarily through
epidemiological studies in which associations between PM and enhanced susceptibility to
viral infections are suggested. Unfortunately, studies that further delve into the underlying
mechanism of this phenomenon in an age appropriate animal model are severely limited.
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Use of an Age-Relevant Model Is Critical
Collectively, the aforementioned observations suggest that there are sensitive life stages
during which exposure to elevated PM has particularly devastating and long-term effects.
Furthermore, the different toxicokinetic and toxicodynamic properties due to age makes
studying an age-relevant model to understand the mechanistic basis for enhanced respiratory
morbidity and mortality crucial.
In age-relevant rodent models, we have observed specific adverse pulmonary effects
including airway hyperresponsiveness, airway remodeling, lung inflammation characterized
by influx of neutrophils in bronchoalveolar lavage fluid (BALF), peribronchial associated
lymphoid tissue, and increased smooth muscle mass following acute (7-day) EPFR
inhalation exposure [70]. These characteristics correspond to noneosinophilic, severe asthma
in humans. Even more strikingly, we observe lung function deficits that persist into early
adulthood (Figure 3) [70], which recapitulates what is seen in humans [71]. In comparison,
adult rodents acutely exposed to combustion-generated ultrafine particles do not exhibit
persistent changes in airway function, reinforcing the need to study these effects in an age
appropriate model.
Clearly, it is important to consider the developmental status of the lung in models used to
study the effects of PM and how interruption/deviation from normal maturation could be
responsible for much of the long-term effects observed in humans. Although relatively little
is known about the mechanism involved in PM-induced airways dysfunction, our data
suggest that airway remodeling plays a major role in long-term dysfunction [70,72].
MECHANISMS INVOLVED
Oxidative Stress
There are many observed and hypothesized mechanisms to explain PM-induced respiratory
effects. One of the most popular involves PM-driven oxidative stress [73–78]. Oxidative
stress results from an impaired ability of antioxidants to protect from harmful ROS. Some of
these include superoxide (O2•–), hydroxyl radical (HO•), and hydrogen peroxide (H2O2). As
discussed above, during combustion processes many different types of molecular pollutants
are able to bind to transition metal-containing particles to form PM-containing EPFRs [22]
and these formed EPFRs have been shown to produce a net output of ROS species in
aqueous media [79]. The exact chemical composition and size of the various PM induce
different amounts and types of oxidative stress. In lungs of neonatal animals and human
bronchoepithelial cell lines (BEAS-2B) exposed to EPFRs, we have observed increased
oxida tive stress following exposure to combustion generated PM [70, 72]. Indicators of
oxidative stress included increases in the ratio of oxidized to reduced glutathione, markers of
lipid peroxidation (e.g., 8-isoprostanes), and decreases in antioxidant enzyme activity
including superoxide dismutase (SOD), catalase, and glutathione peroxidase. These effects
were specifically related to the presence of the EPFR, since size-controlled non-EPFR
particles failed to induce significant amounts of oxidative stress either in vivo or in vitro.
The overall role of oxidative stress in the development/exacerbation of lung disease is
becoming apparent. Lipid peroxidation indicators such as malondialdehyde have been
observed as biomarkers for PM-induced increases in oxidative stress in children with asthma
[80]. This is thought to happen as both direct and indirect damage to the lung parenchyma;
PM reacts directly with tissue to produce hydroxyl radicals via surface chemistry and
indirectly through the actions of inflammatory cell influx. It has also been suggested that the
ability to handle oxidative stress is altered in the lungs of asthmatics [81], leading to
excessive ROS and its downstream effects (i.e., airway remodeling).
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Other studies have shown a relationship between oxidative stress and both innate and
adaptive immune function. In particular, ozone (O3) exposure induces increased cell surface
expression of proteins intricately involved in sensing invading pathogens (e.g., toll-like
receptor 4 (TLR4)). With O3 challenge, TLR4 expression increases and is responsible for
enhanced immune responses to inhaled allergens in mice [82]. This effect has also been
observed in healthy human subjects exposed to O3 [83, 84]. Oxidative stress also mediates
the release of proinflammatory cytokines and increases antigen presentation because of
immunosuppressive cytokine interleukin 10 (IL-10) downregulation leading to increased
sensitivity and inflammation [85]. The role of oxidative stress and defense from oxidative
damage is also an important factor in viral infection as demonstrated by higher viral burden
in mice with antioxidantdeficient diets [86] and the attenuation of infection with treatment
with the antioxidant glutathione [87].
PM exposure can also lead to changes in the development of adaptive immunity. Diesel
exhaust particles, ambient PM, and O3 have all been shown to act as adjuvants in rodent
models of inflammatory airways disease [88,89]. More recent studies have demonstrated the
direct effects of PM on mediators of adaptive immunity. With PM exposure, pulmonary
dendritic cells (DCs), the professional antigen presenting cells of the immune system,
increase in number and activation status [90], whereas T cells demonstrate greater
proliferative ability [91]. We have also observed the exacerbating potential of EPFR-
containing PM during coexposure with allergen (OVA) in sensitized adults (data not
shown). Interestingly, while these adjuvant-like effects of PM foster a heightened
inflammatory response in adults, the infant immune system is very different and such
heightened inflammatory responses can be quite detrimental in inhibiting adequate
respiratory gas exchange and are thus often suppressed.
While our data suggest EPFR-mediated oxidative damage to neonatal lungs, there exist a
plethora of data demonstrating that neonates are more resistant to oxidative damage as
compared to adults [92, 93]. However, the actual data on this subject are less clear. SOD
activity in most strains of mice increases naturally with age and peaks at 25 weeks of age
[94], and SOD-2 has been shown to be induced by cytokines including IL-1β and TNFα
both in vitro [95] and in vivo [96] models of hyperoxia; and neonates express these
cytokines in higher amounts than adult mice [93]. Cumulatively, these data suggests an
“oxidative-resistant” phenotype and that during this unique developmental period, the
neonate is better equipped at handling additional oxidative damage to an extent because their
bodies are primed to prepare for their first encounter with oxygen (i.e., SOD-1 activity is
“programmed” to increase shortly after birth and the signals for SOD-2 induction are easily/
rapidly produced). This is contrary to adults where the oxidant/antioxidant balance has been
well established, and subsequent insults prove detrimental.
Although neonatal mice have been shown to be more resistant to oxidative stress, severe
focal alveolitis has been observed in response to hyperoxia indicating that pulmonary injury
still occurs and is a major concern given the developmental status of the lung [93].
Consistent with this finding, our data show EPFR-containing PM cause alveolar septal
destruction at a much higher degree than non-EPFR PM [70],, suggesting some oxidative
component.
Infant Immunity: An Age Naturally at Risk
Shortly after birth, the neonatal immune system is bombarded with antigens, particularly at
surfaces with high external exposure such as the respiratory tract. Neonates and infants must
deal with pathogens using both innate immunity, mediated by pattern recognition receptors
including TLRs, and adaptive immunity, mediated by helper and cytotoxic T cells and B
cells. As previously stated, the infant immune system is very different from that of the adult.
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Innate immunity in the infant is impaired and characterized by selective TLR signaling (i.e.,
reduced overall TLR expression; responses to TLR8 ligands, and little-to-no responses to
TLR1-7 ligands) and reduced ability to produce proinflammatory and Th1 cytokines (TNFα,
IFNγ ) upon TLR stimulation [97]. In addition, adaptive immunity in the infants is also very
different from that of a mature adult. Neonates have impaired Th1 (IFN-γ , IL-12) responses
but preserved Th2 responses (IL-4, IL-13) due to epigenetic differences (hypermethylation
and hypomethylation, respectively) at cytokine regulatory regions [98–102]. This early bias
is thought to be a result, at least in part, of the actions of immature DCs. Neonatal DCs
display attenuated recruitment to the lung [103, 104] and a lower production of IL-12
leading to suppressed Th1 responses and resulting in Th2-biased responses [105]. In
addition to suppressed Th1 responses, PM has been shown to suppress regulatory T cells
(Treg) through hypermethylation of the Treg-transcription factor Foxp3 in the peripheral
blood of children with asthma [106]. Our own data suggest that PM exposure in neonates
initially causes an enhanced Treg response followed by a suppression of effector T helper
(Th1 and Th2) responses to antigen such as influenza or ovalbumin. The implications of this
are that early life exposure to PM creates a suppressive immune environment in the lung
whereby the infant immune system cannot generate a protective effector T cell response to
certain antigens/pathogens, resulting in enhanced disease. Since adaptive immunity relies on
this initial response to “adapt,” reexposure to the same antigen at a subsequent time point
invokes an altered, more heterogeneous immune response that is also less protective (Figure
4). Whether this phenomena is PM composition-specific remains to be seen.
Size of PM Is Important in Predicting Respiratory Impact
We have previously reported that in a human laryngeal epithelial cell line, EPFR-containing
particles 2.5 μm in diameter (EPFR2.5) are able to continuously generate H2O2, while
modifying the activities of antioxidant enzymes associated with the neutralization of H2O2
(i.e., catalase) [76]. No significant change in the activity of SOD was observed suggesting
that O2•– is not generated in exposed cells. The significant generation of oxidized
phospholipids (i.e., 8-isoprostanes) in the culture supernatants, along with the fact that H2O2
readily diffuses across the cell membrane, indicated that EPFR2.5 induces the generation of
ROS outside of the cell. In vivo studies demonstrated that EPFR2.5 induces only limited
effects on pulmonary redox balance, increasing SOD activity and decreasing catalase
activity, and not altering glutathione peroxidase activity or glutathione balance [76].
In contrast, our data using EPFR-containing particles 0.2 μm in diameter (EPFR0.2) have
shown marked effects including drastic increases in oxidative stress and significant airway
remodeling [70, 72]. EPFR0.2 exposure increased the oxidized: reduced glutathione ratio and
the level of the lipid peroxidation marker, 8-isoprostanes, in our neonatal rodent exposure
model. In association with oxidative stress, we observed epithelial-to-mesenchymal
transitions in vitro in EPFR0.2-exposed primary neonatal epithelial cells and in vivo in
EPFR0.2-exposed neonatal mice and rats [72]. With multiple days of exposure, smooth
muscle mass underlying the bronchial epithelium was increasingly greater and septal
lesioning was evident in the alveoli.
Cumulatively, these data indicate that EPFR2.5 generates H2O2 in the lungs of exposed
neonatal animals whereas EPFR0.2 are able to penetrate much deeper into alveoli altering
antioxidant capabilities. More interestingly, our data suggest that the pulmonary antioxidant
defense system exhibits site-specific activity (i.e., catalase is essential in neutralization of
ROS generated in the epithelial cells of the trachea and bronchi, and glutathione peroxidase
is the main antioxidant involved in detoxification of oxidants in the alveolar region). This is
supported by other published observations [107–109] and further suggests that the impact
effect of EPFRs is limited to their site of deposition, which in the neonatal rodent lung
means that EPFR2.5 affects mainly the terminal bronchioles and EPFR0.2 affects the
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developing acinar structures. Our results are supported by recent experimental data
demonstrating that ultrafine particle deposition occurs in the developing alveoli in neonatal
rat lungs [110]. The human infant lung and respiratory system are obviously larger than that
of an adult rat/mouse, much less an infant rat/mouse, suggesting that the independent size
effects observed in the rodent models will occur simultaneously in the human infant.
Various models of age-dependent particulate deposition in different lung compartments have
shown that infants are alarmingly twice as susceptible to ultrafine particle deposition
compared to adults and that most accumulation occurs in the alveolar region of the lower
airways [111].
Barrier Dysfunction and Airway Disease
The respiratory epithelium is the first layer of defense against pollutants and aeroallergens.
The protective function of the epithelium is maintained through the expression of proteins
that allow for tight cell–cell adhesion (E-cadherin, β-catenin, zona occludins 1–3). Patients
with asthma readily display reduced expression of these junctional proteins [112], and
confluent cultures of cells from asthmatics display decreased transepithelial resistance,
which indicates monolayer permeability and a heightened vulnerability to antigen and
possibly pathogen access to the basement membrane [113]. Cigarette smoke extract (which
contains EPFR-containing PMs) induces decreased transepithelial resistance and increased
permeability to aeroallergens such as house dust mite (HDM) in vitro [114].
Our own research using EPFRs in an acute animal exposure model has demonstrated
damaging effects of PM on airway epithelium [72]. Within 4 days of exposure, the cells
lining the epithelium appear to be highly proliferative with decreased cell:cell junctions and
increased epithelial membrane permeability. In subsequent exposure days, this is
accompanied by a significant increase in airway remodeling made evident by massive
increases in smooth muscle cell mass and number surrounding the airways (Figure 5).
Interestingly, disruption of the bronchial epithelium also strongly effects epithelial:DC
interactions. Such interactions are crucial in dictating DC maturation and the ensuing
immune response. At homeostatic baseline, free β-catenin in the cytosol of airway DCs is
scarce, since it is either tethered to the cell membrane by E-cadherin [115] (which allows
adherence to epithelial cells) or it is targeted for proteolytic degradation [116]. Cytosolic β-
catenin is only observed under conditions of disrupted E-cadherin-mediated adhesion of
epithelial cells and DCs or when wingless (Wnt) signaling is activated. Accumulation of
cytosolic β-catenin eventually results in nuclear translocation and the initiation of various
transcription events including Serpine1 and Snail1 [115] and is strongly associated with
IL-10+ regulatory DCs [117]. Since many aeroallergens, including HDM, display intrinsic
protease activity as well as signaling capabilities that can drive epithelialto-mesenchymal
transition [118], it must be noted that the continuous interaction between these two factors
could be synergistic in promoting airway dysfunction and remodeling as well as affecting
development of adaptive immune responses. This is something that we are vigorously
investigating.
CONCLUSION AND PERSPECTIVE
EPFR-PM exposure disproportionately affects infants and children and is the cause of
significant global mortality and morbidity. Infants/neonates represent a sensitive life stage
with unique PM-induced pulmonary disease. Knowledge of the impact of PM on the
protective epithelial layer of the respiratory tract along with how that damage modulates
long-term immune responses should lead to a focus on how these responses affect the
developing neonatal lung and immune system. While much correlative epidemiological data
exist, there is currently little-to-no literature establishing a mechanism in infants. Our studies
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have shown that the influence of EPFR-containing PM on the developing epithelium proves
to be of great significance in modifying functional physiology as well as immunity.
Ultimately, understanding infant susceptibility and how it affects allergic sensitization/
asthma will open doors to new treatments and preventative therapeutics and more
importantly, help promote and mold new legislative policies aimed at reducing
environmental exposures to reduce these preventable adverse health consequences in
addition to saving millions in healthcare dollars.
PM-induced pulmonary disease is a neglected area of global health that affects a large
proportion of the world's population. It has become increasingly clear that properties of the
various PM are responsible for the observed health effects. This presents a challenge to
researchers due to the extreme variability in content of “real-world” PM samples.
Differences in sampling methods, extraction methods, dosing concentrations, exposure
models, etc. could prove to be monumentally responsible for the variability seen in
experimental results. Combustion, laboratory-generated PM offers some advantages such as
increased reproducibility but lacks the full spectra of “ingredients” that may also prove to be
vitally important in the initiation of health effects. Looking forward, the most pressing areas
of research are
• Improved exposure assessment methodologies:
– to more accurately assess airborne PM associated toxicants (e.g., EPFRs)
– to understand how sample collection, extraction, and other downstream
treatments alter the chemical species of the sample
– to assess the effect of “storage time” on the biological activity of the
environmental samples
• Additional toxicological studies:
– to help determine acute and long-term health risks
– to develop viable intervention therapeutics
– to identify biomarkers to aid epidemiological studies and determine level
of present and past exposure
• Additional epidemiological studies to examine the effect on:
– infectious disease severity and outcomes
– growth and development
– other disease states (e.g., diabetes, cardiovascular disease)
These important issues must be addressed in order for accurate and unbiased conclusions to
be drawn from PM research and for the true health impacts of EPFR-particle systems to be
elucidated.
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Persistency of EPFRs in mouse BALF. EPFR-containing PM (2-MCP on 3% CuO/silica)
were suspended in BALF and shaken continuously. At the indicated times, samples were
centrifuged for 5 min; and the liquid fraction discarded and the particle fraction retained.
Particles were frozen at –25°C and dried in a vacuum for 12 h at room temperature. The
analysis of the EPR analysis of the particles demonstrated the presence of paramagnetic
signal with a characteristic g value of 2.0042 and a peak width of ~8 Gauss (inset). These
spectra were similar to preexposure samples and are characteristic to the presence of EPFRs
associated with particles. The position and width of the radical signal was not affected by
incubation in BALF; however, the intensity (i.e., the number of radicals) diminished with
increasing incubation time.
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Pubmed Search Results. (A) Number of publications available on asthma and particulate
matter. Search conducted on May 23, 2012. (B). Number of published articles available on
influenza and child respiratory and particulate matter. Search conducted on May 21, 2012.
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Airways hyperreactivity following neonatal exposure to EPFR-containing PM persists in the
adult. Neonatal rodents were exposed to EPFR-containing PM or control air for 7
consecutive days then allowed to mature to 8 weeks of age. Enhanced pause (Penh), a
derived measure of airways hyperresponsiveness, was measured with increasing doses of
inhaled methacholine using whole body plethysmography. n = 6–8 animals/group. *p < 0.05
Two-way ANOVA.
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Neonatal exposure to EPFR-containing PM causes an early Treg response that dampens
subsequent effector T cell responses to antigen. (A) Descriptive overview. (B) Responses
observed in our lab using our neonatal PM exposure model. With exposure beginning on day
3 of age, we see an increase in the amount of Tregs present in the lung that peaks around the
fifth day of exposure. When the lung is given an additional insult at this time (e.g., allergen,
influenza), effector T cell responses are dampened compared to nonexposed controls given
the same challenge.
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Neonatal acute exposure to EPFR0.2 causes airway remodeling. (Top panel) Light
micrographs of terminal bronchioles from 15-day old rat lungs exposed to control air, non-
EPFR0.2 (DCB50), or EPFR0.2 (DCB230). Black arrows denote significant bronchiolar
associated lymphoid tissue (BALT), and black line denotes significant increases in smooth
muscle mass surrounding bronchiole. (Bottom panel) Micrographs of lung sections stained
by immunohistochemistry for E-cadherin (green), α-smooth muscle actin (red), and cell
nuclei (blue) with quantitative assessment of smooth muscle layer (inset). Figure adapted
from Balakrishna et al. [70]. BioMed Central.
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